Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Nov;30(11):9093-9100.
doi: 10.1007/s00520-022-07330-w. Epub 2022 Aug 19.

Effect of heated humidified high-flow nasal cannula (HFNC) oxygen therapy in dyspnea patients with advanced cancer, a randomized controlled clinical trial

Affiliations
Randomized Controlled Trial

Effect of heated humidified high-flow nasal cannula (HFNC) oxygen therapy in dyspnea patients with advanced cancer, a randomized controlled clinical trial

Zhaoning Xu et al. Support Care Cancer. 2022 Nov.

Abstract

Purpose: Heated humidified high-flow nasal cannula (HFNC) oxygen therapy is one of the most important oxygen therapy methods, which are commonly applied to relieve dyspnea in advanced cancer patients. Our study aims to observe the efficacy and safety of HFNC oxygen therapy on dyspnea patients with advanced cancer and explore the clinical application.

Methods: Sixty subjects with advanced cancer requiring oxygen therapy from a grade 3, class A hospital in China were recruited and randomized (1:1) to traditional nasal catheter oxygen therapy or HFNC. Primary outcomes were dyspnea, oral dryness, and sleep condition, which were recorded after 72-h treatment. Secondary outcomes were heart rate (HR), respiration rate (RR), SpO2, PaO2, and PaCO2, which were recorded after 2, 6, 24, and 72 h treatment.

Results: Seventy-two hours after treatment, there were significant improvements in all primary outcomes (P < 0.001). PaO2 and RR were statistically changed 2 h after HFNC treatment (P < 0.001). PaCO2 and HR were statistically changed 24 h after HFNC treatment (P < 0.001).

Conclusion: HFNC oxygen therapy has good effect, high safety, and is easy to be accepted by dyspnea patients with advanced cancer. It can be used as the first choice of oxygen therapy for these patients and has broad clinical prospects.

Trial registration: This work was retrospectively registered in the Chinese Clinical Trials Registry (ChiCTR2100049582) on August 4, 2021.

Keywords: Dyspnea; Neoplasms; Oxygen inhalation therapy; Patient comfort; Randomized controlled trial.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660 - DOI - PubMed
    1. Tishelman C, Petersson L-M, Degner LF et al (2007) Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death. J Clin Oncol 25:5381–5389. https://doi.org/10.1200/jco.2006.08.7874 - DOI - PubMed
    1. Maltoni M, Caraceni A, Brunelli C et al (2005) Prognostic factors in advanced cancer patients: evidence-based clinical recommendations — a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 23:6240–6248. https://doi.org/10.1200/jco.2005.06.866 - DOI - PubMed
    1. Tanaka K, Akechi T, Okuyama T et al (2002) Impact of dyspnea, pain, and fatigue on daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage 23:417–423. https://doi.org/10.1016/s0885-3924(02)00376-7 - DOI - PubMed
    1. Gupta D, Lis CG, Grutsch JF (2007) The relationship between dyspnea and patient satisfaction with quality of life in advanced cancer. Support Care Cancer 15:533–538. https://doi.org/10.1007/s00520-006-0178-7 - DOI - PubMed

Publication types

LinkOut - more resources